CDK5 and neurodegenerative disease: In addition, they also show potent inhibition against kinases related with neurodegenerative diseases, such as cyclic-dependent kinase 5 (CDK5), glycogen synthase kinase 3b (GSK3b) and casein kinase I (CD1d) [116].